TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2021/12 | 2020/12 |
Turnover |
274,487
|
177,340
|
167,389 |
Financial expenses |
891
|
537
|
73 |
Earnings before taxes |
4,956
|
5,209
|
4,249 |
EBITDA |
6,011
|
5,885
|
4,490 |
Total assets |
157,132
|
192,363
|
162,428 |
Current assets |
156,960
|
191,957
|
161,864 |
Current liabilities |
55,028
|
78,953
|
131,342 |
Equity capital |
29,477
|
29,789
|
26,565 |
- share capital |
126
|
145
|
148 |
Employees (average) |
46
|
40
|
38 |
Financial ratios
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Solvency |
18.8%
|
15.5%
|
16.4% |
Turnover per employee |
5,967
|
4,434
|
4,405 |
Profit as a percentage of turnover |
1.8%
|
2.9%
|
2.5% |
Return on assets (ROA) |
3.7%
|
3.0%
|
2.7% |
Current ratio |
285.2%
|
243.1%
|
123.2% |
Return on equity (ROE) |
16.8%
|
17.5%
|
16.0% |
Change turnover |
120,461
|
13,120
|
8,182 |
Change turnover % |
78%
|
8%
|
5% |
Chg. No. of employees |
6
|
2
|
3 |
Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.